CU20140133A7 - COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX - Google Patents

COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX

Info

Publication number
CU20140133A7
CU20140133A7 CU2014000133A CU20140133A CU20140133A7 CU 20140133 A7 CU20140133 A7 CU 20140133A7 CU 2014000133 A CU2014000133 A CU 2014000133A CU 20140133 A CU20140133 A CU 20140133A CU 20140133 A7 CU20140133 A7 CU 20140133A7
Authority
CU
Cuba
Prior art keywords
methods
chelate complex
compositions
polypeptides
oligonucleotide chelate
Prior art date
Application number
CU2014000133A
Other languages
Spanish (es)
Inventor
Michel Bazinet
Andrew Vaillant
Original Assignee
Replicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2013/050379 external-priority patent/WO2013170386A1/en
Application filed by Replicor Inc filed Critical Replicor Inc
Publication of CU20140133A7 publication Critical patent/CU20140133A7/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composición farmacéutica que contiene un complejo de quelato de oligonucleótido y al menos un polipéptido o polipéptido pegilado. La presente descripción también describe composiciones farmacéuticas adicionales y métodos para el tratamiento de enfermedades que incluyen infecciones virales.A pharmaceutical composition containing an oligonucleotide chelate complex and at least one pegylated polypeptide or polypeptide is described. The present description also describes additional pharmaceutical compositions and methods for the treatment of diseases that include viral infections.

CU2014000133A 2012-08-30 2014-11-18 COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX CU20140133A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261695035P 2012-08-30 2012-08-30
PCT/CA2013/050379 WO2013170386A1 (en) 2012-05-18 2013-05-17 Oligonucleotide chelate complex-polypeptide compositions and methods

Publications (1)

Publication Number Publication Date
CU20140133A7 true CU20140133A7 (en) 2015-03-30

Family

ID=53365658

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2014000133A CU20140133A7 (en) 2012-08-30 2014-11-18 COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX

Country Status (1)

Country Link
CU (1) CU20140133A7 (en)

Similar Documents

Publication Publication Date Title
CL2015000295A1 (en) Compounds derived from alkylpyrimidine; pharmaceutical composition that includes them; Use for the treatment of viral infections and other diseases.
CO7131387A2 (en) Compositions and methods of oligonucleotide chelate complex-polypeptides
UY34701A (en) SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFIT
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
ECSP12012318A (en) PIRAZOLIL QUINAZOLINA CINASA INHIBITORS
CL2013003019A1 (en) Compounds derived from benzothiazole; pharmaceutical composition that includes them; and its use in the treatment of hiv.
MY165124A (en) Semifluorinated alkane compositions
BR112015024411A2 (en) macrocyclic desaza purinones for the treatment of viral infections
CL2015000784A1 (en) Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases.
SV2018005621A (en) INHIBITOR OF MUTED DEHYDROGENASE ISOCITRATE IDH1 R132H
DOP2016000253A (en) NEW COMPOUNDS
BR112014025041B8 (en) PHARMACEUTICAL COMPOSITION
BR112017012406A2 (en) fixed ratio formulation of insulin glargine / lixisenatide
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
IN2014CN00572A (en)
BR112014013972A8 (en) hcv inhibitors nssa
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
DOP2016000251A (en) WNT SIGNALING ROAD INHIBITORS
BR112015002979B8 (en) Crystalline form and pharmaceutical composition
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
UY34552A (en) CRYSTAL FORM DELTA OF THE ARGININE SALT OF PERINDOPRILE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
DOP2017000115A (en) PHARMACEUTICAL COMPOSITIONS OF PROLONGED ACTION FOR HEPATITIS C
DOP2017000116A (en) PROLONGED COMBINATION ACTION COMPOSITIONS AND PROCEDURES FOR HEPATITIS C
CL2016001054A1 (en) Compounds for the treatment of diabetes and complications of diseases derived from it
CU20140133A7 (en) COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX